Trial
NCT02742883
A Study of Atengenal and Astugenal in Diffuse, Intrinsic Pontine Glioma (DIPG)
Phase IISUSPENDEDSAFETYConfidence: MEDIUM
Sponsor
Burzynski Research Institute
Collaborators
—
Condition
Diffuse, Intrinsic Pontine Glioma
Intervention
Antineoplaston therapy (Atengenal + Astugenal)
Why stopped
Clinical Hold
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-09-16